These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27269956)

  • 1. Safety of Intravenous Methamphetamine Administration During Ibudilast Treatment.
    DeYoung DZ; Heinzerling KG; Swanson AN; Tsuang J; Furst BA; Yi Y; Wu YN; Moody DE; Andrenyak DM; Shoptaw SJ
    J Clin Psychopharmacol; 2016 Aug; 36(4):347-54. PubMed ID: 27269956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ibudilast attenuates peripheral inflammatory effects of methamphetamine in patients with methamphetamine use disorder.
    Li MJ; Briones MS; Heinzerling KG; Kalmin MM; Shoptaw SJ
    Drug Alcohol Depend; 2020 Jan; 206():107776. PubMed ID: 31812878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, Placebo-Controlled Trial of Targeting Neuroinflammation with Ibudilast to Treat Methamphetamine Use Disorder.
    Heinzerling KG; Briones M; Thames AD; Hinkin CH; Zhu T; Wu YN; Shoptaw SJ
    J Neuroimmune Pharmacol; 2020 Jun; 15(2):238-248. PubMed ID: 31820289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice.
    Snider SE; Vunck SA; van den Oord EJ; Adkins DE; McClay JL; Beardsley PM
    Eur J Pharmacol; 2012 Mar; 679(1-3):75-80. PubMed ID: 22306241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study.
    Worley MJ; Swanson A-N; Heinzerling KG; Roche DJ; Shoptaw S
    Drug Alcohol Depend; 2016 May; 162():245-50. PubMed ID: 26993372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pharmacology of the methamphetamine stereoisomers.
    Mendelson J; Uemura N; Harris D; Nath RP; Fernandez E; Jacob P; Everhart ET; Jones RT
    Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of intravenous methamphetamine administration during treatment with bupropion.
    Newton TF; Roache JD; De La Garza R; Fong T; Wallace CL; Li SH; Elkashef A; Chiang N; Kahn R
    Psychopharmacology (Berl); 2005 Nov; 182(3):426-35. PubMed ID: 16163531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
    Miles SW; Sheridan J; Russell B; Kydd R; Wheeler A; Walters C; Gamble G; Hardley P; Jensen M; Kuoppasalmi K; Tuomola P; Föhr J; Kuikanmäki O; Vorma H; Salokangas R; Mikkonen A; Kallio M; Kauhanen J; Kiviniemi V; Tiihonen J
    Addiction; 2013 Jul; 108(7):1279-86. PubMed ID: 23297867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans.
    Kirkpatrick MG; Gunderson EW; Johanson CE; Levin FR; Foltin RW; Hart CL
    Addiction; 2012 Apr; 107(4):783-91. PubMed ID: 22050030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse.
    Beardsley PM; Shelton KL; Hendrick E; Johnson KW
    Eur J Pharmacol; 2010 Jul; 637(1-3):102-8. PubMed ID: 20399770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers.
    De La Garza R; Zorick T; Heinzerling KG; Nusinowitz S; London ED; Shoptaw S; Moody DE; Newton TF
    Pharmacol Biochem Behav; 2009 Nov; 94(1):186-93. PubMed ID: 19698734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: feasibility, tolerability and clinical outcomes.
    Lee N; Pennay A; Hester R; McKetin R; Nielsen S; Ferris J
    Drug Alcohol Rev; 2013 Jan; 32(1):88-95. PubMed ID: 22630616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses.
    Rolan P; Gibbons JA; He L; Chang E; Jones D; Gross MI; Davidson JB; Sanftner LM; Johnson KW
    Br J Clin Pharmacol; 2008 Dec; 66(6):792-801. PubMed ID: 19032723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine.
    Reynolds AR; Strickland JC; Stoops WW; Lile JA; Rush CR
    Drug Alcohol Depend; 2017 Dec; 181():25-29. PubMed ID: 29028556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial.
    Rezaei F; Ghaderi E; Mardani R; Hamidi S; Hassanzadeh K
    Fundam Clin Pharmacol; 2016 Jun; 30(3):282-9. PubMed ID: 26751259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial Attenuation With Ibudilast in the Treatment of Medication Overuse Headache: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial of Efficacy and Safety.
    Johnson JL; Kwok YH; Sumracki NM; Swift JE; Hutchinson MR; Johnson K; Williams DB; Tuke J; Rolan PE
    Headache; 2015 Oct; 55(9):1192-208. PubMed ID: 26367865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
    Johnson BA; Ait-Daoud N; Elkashef AM; Smith EV; Kahn R; Vocci F; Li SH; Bloch DA;
    Int J Neuropsychopharmacol; 2008 Feb; 11(1):1-14. PubMed ID: 17470315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose.
    Li L; Lopez JC; Galloway GP; Baggott MJ; Everhart T; Mendelson J
    Ther Drug Monit; 2010 Aug; 32(4):504-7. PubMed ID: 20592647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K
    Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.